SCHEMBL1709243

SCHEMBL1709243

Cc1ccccc1CNCC1CC12CCN(c1ccccc1)CC2

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 5/20 0.52
CXCR4 P61073 1/20 0.43
LMNA P02545 2/20 0.40
KDM4E B2RXH2 1/20 0.40
POLB P06746 1/20 0.39
MAPT P10636 1/20 0.39
CHRM2 P08172 1/20 0.38
HTR2A P28223 1/20 0.38
HTR2C P28335 1/20 0.38
HTR2B P41595 1/20 0.38
CYP2A13 Q16696 1/20 0.37
ACHE P22303 1/20 0.36
TP53 P04637 1/20 0.35
CYP2D6 P10635 2/20 0.35
CHRM4 P08173 1/20 0.35
MAPK1 P28482 2/20 0.35
MEN1 O00255 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C19 P33261 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1709217 0.88 SCN9A (0.48) SCN9ALMNAHTR2AHTR2CHTR2B
SCHEMBL1709251 0.81 SCN9A (0.54) SCN9ACXCR4KDM4EMAPTACHE
SCHEMBL10071960 0.77 SCN9A (0.49) SCN9ACXCR4KDM4EMAPTTP53
SCHEMBL1709240 0.77 SCN9A (0.60) SCN9AKDM4ECYP2D6MAPK1MEN1
SCHEMBL1709237 0.75 SCN9A (0.58) SCN9AHTR2A
SCHEMBL10072038 0.73 SCN9A (0.53) SCN9ALMNACYP2D6CHRM4MAPK1
SCHEMBL1709241 0.73 SCN9A (0.54) SCN9AKDM4ECYP2D6MAPK1CYP3A4
SCHEMBL10071959 0.72 CCR3 (0.51) SCN9AMEN1CYP3A4KMT2AUSP2
SCHEMBL1709252 0.69 SCN9A (0.56) SCN9ALMNAMEN1KMT2A
SCHEMBL1709238 0.69 SCN9A (0.59) SCN9ALMNAPOLBMAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012047703-A2 CYCLOPROPYL-SPIRO-PIPERIDINES USEFUL AS SODIUM CHANNEL BLOCKERS SCHERING CORPORATION (US) 2012-04-12 WO disclosed